NM_015330.6:c.562C>T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_015330.6(SPECC1L):​c.562C>T​(p.Leu188Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00654 in 1,614,182 control chromosomes in the GnomAD database, including 71 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0074 ( 10 hom., cov: 33)
Exomes 𝑓: 0.0064 ( 61 hom. )

Consequence

SPECC1L
NM_015330.6 missense

Scores

7
4
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.34

Publications

10 publications found
Variant links:
Genes affected
SPECC1L (HGNC:29022): (sperm antigen with calponin homology and coiled-coil domains 1 like) This gene encodes a coiled-coil domain containing protein. The encoded protein may play a critical role in actin-cytoskeletal reorganization during facial morphogenesis. Mutations in this gene are a cause of oblique facial clefting-1. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. A read-through transcript composed of SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1-like) and the downstream ADORA2A (adenosine A2a receptor) gene sequence has been identified, but it is thought to be non-coding. [provided by RefSeq, Jun 2013]
SPECC1L-ADORA2A (HGNC:49185): (SPECC1L-ADORA2A readthrough (NMD candidate)) This locus represents naturally occurring readthrough transcription between the neighboring SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1-like) and ADORA2A (adenosine A2a receptor) genes on chromosome 22. The readthrough transcript is a candidate for nonsense-mediated mRNA decay (NMD) and is unlikely to produce a protein product. [provided by RefSeq, Jun 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0059348345).
BP6
Variant 22-24321542-C-T is Benign according to our data. Variant chr22-24321542-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445410.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 1134 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPECC1LNM_015330.6 linkc.562C>T p.Leu188Phe missense_variant Exon 5 of 17 ENST00000314328.14 NP_056145.5 Q69YQ0-1B2RMV2
SPECC1LNM_001145468.4 linkc.562C>T p.Leu188Phe missense_variant Exon 4 of 16 NP_001138940.4 B2RMV2
SPECC1LNM_001254732.3 linkc.562C>T p.Leu188Phe missense_variant Exon 4 of 15 NP_001241661.3 Q69YQ0-2
SPECC1L-ADORA2ANR_103546.1 linkn.870C>T non_coding_transcript_exon_variant Exon 5 of 20

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPECC1LENST00000314328.14 linkc.562C>T p.Leu188Phe missense_variant Exon 5 of 17 1 NM_015330.6 ENSP00000325785.8 Q69YQ0-1
SPECC1L-ADORA2AENST00000358654.2 linkn.562C>T non_coding_transcript_exon_variant Exon 5 of 20 2 ENSP00000351480.2 F8WAN1

Frequencies

GnomAD3 genomes
AF:
0.00745
AC:
1134
AN:
152204
Hom.:
10
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000941
Gnomad AMI
AF:
0.0318
Gnomad AMR
AF:
0.00850
Gnomad ASJ
AF:
0.00836
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0308
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00807
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00767
AC:
1930
AN:
251468
AF XY:
0.00781
show subpopulations
Gnomad AFR exome
AF:
0.000861
Gnomad AMR exome
AF:
0.00408
Gnomad ASJ exome
AF:
0.0106
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0294
Gnomad NFE exome
AF:
0.00819
Gnomad OTH exome
AF:
0.00961
GnomAD4 exome
AF:
0.00644
AC:
9415
AN:
1461860
Hom.:
61
Cov.:
32
AF XY:
0.00642
AC XY:
4667
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.000836
AC:
28
AN:
33480
American (AMR)
AF:
0.00443
AC:
198
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00884
AC:
231
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00143
AC:
123
AN:
86256
European-Finnish (FIN)
AF:
0.0265
AC:
1417
AN:
53390
Middle Eastern (MID)
AF:
0.0140
AC:
81
AN:
5768
European-Non Finnish (NFE)
AF:
0.00626
AC:
6963
AN:
1112010
Other (OTH)
AF:
0.00619
AC:
374
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
648
1295
1943
2590
3238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00744
AC:
1134
AN:
152322
Hom.:
10
Cov.:
33
AF XY:
0.00836
AC XY:
623
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000938
AC:
39
AN:
41570
American (AMR)
AF:
0.00849
AC:
130
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00836
AC:
29
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4824
European-Finnish (FIN)
AF:
0.0308
AC:
327
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00807
AC:
549
AN:
68028
Other (OTH)
AF:
0.0113
AC:
24
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
62
125
187
250
312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0107
Hom.:
761
Bravo
AF:
0.00587
TwinsUK
AF:
0.00512
AC:
19
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00802
AC:
69
ExAC
AF:
0.00723
AC:
878
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00889
EpiControl
AF:
0.00830

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SPECC1L: BS2 -

Aug 29, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oculomaxillofacial dysostosis;CN306405:Teebi hypertelorism syndrome 1 Benign:1
Apr 25, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.76
BayesDel_addAF
Benign
-0.012
T
BayesDel_noAF
Pathogenic
0.22
CADD
Uncertain
25
DANN
Uncertain
1.0
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Pathogenic
0.98
.;D;.;.;D
MetaRNN
Benign
0.0059
T;T;T;T;T
MetaSVM
Uncertain
0.038
D
PhyloP100
3.3
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-2.0
N;N;N;N;D
REVEL
Benign
0.25
Sift
Pathogenic
0.0
D;D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;D
Vest4
0.75
MVP
0.72
MPC
1.3
ClinPred
0.017
T
GERP RS
5.6
gMVP
0.43
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56168869; hg19: chr22-24717510; COSMIC: COSV100063606; API